Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study

International Journal of Cancer

Volumn 128, Issue 11, 2011, Pages 2717-2725

  Lemmens, Valery E ^a,b,e   Klaver, Yvonne L ^c   Verwaal, Vic J ^d   Rutten, Harm J ^c   Coebergh, Jan Willem W ^a,b   De Hingh, Ignace H ^c  

^a Eindhoven Cancer Registry   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e IKZ   (Netherlands)

Author keywords

colorectal cancer; incidence; metastases; peritoneal carcinomatosis; survival

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NETHERLANDS; PERITONEAL NEOPLASMS; PROGNOSIS;

EID: 79953306491     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25596     Document Type: Article

References (35)

1. Alberts SR, Wagman LD,. Chemotherapy for colorectal cancer liver metastases. Oncologist 2008; 13: 1063-73.
2. Ceelen WP, Bracke ME,. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment. Lancet Oncol 2009; 10: 72-9.
3. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22: 3284-92. (Pubitemid 41103684)
4. Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S,. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007; 245: 597-603. (Pubitemid 46555664)
5. Yan TD, Black D, Savady R, Sugarbaker PH,. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006; 24: 4011-9. (Pubitemid 46630752)
6. Hagendoorn J, van Lammeren G, Boerma D, van der Beek E, Wiezer MJ, van Ramshorst B,. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. Eur J Surg Oncol 2009; 35: 833-7.
7. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H,. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-32.
8. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, Lorimier G, Dube P, Glehen O,. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol; 28: 63-8.
9. Jayne DG, Fook S, Loi C, Seow-Choen F,. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-50. (Pubitemid 35404323)
10. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP,. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243: 212-22. (Pubitemid 43185440)
11. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ,. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22: 369-76. (Pubitemid 23208931)
12. UICC. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss, 2002.
13. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents. Lyon: IARC Scientific Publications, 1997.
14. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC,. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364-7. (Pubitemid 19035034)
15. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT,. Potentially curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol 1988; 6: 106-18. (Pubitemid 18039998)
16. Franiel T, Diederichs G, Engelken F, Elgeti T, Rost J, Rogalla P,. Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions. Abdom Imaging 2009; 34: 49-54.
17. de Bree E, Koops W, Kroger R, van Ruth S, Witkamp AJ, Zoetmulder FA,. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 2004; 86: 64-73. (Pubitemid 38580516)
18. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH,. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993; 72: 1631-6. (Pubitemid 23249290)
19. Davies J, Chalmers AG, Sue-Ling HM, May J, Miller GV, Martin IG, Johnston D,. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 1997; 41: 314-9. (Pubitemid 27428188)
20. Knorr C, Reingruber B, Meyer T, Hohenberger W, Stremmel C,. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities. Int J Colorectal Dis 2004; 19: 181-7. (Pubitemid 38528881)
21. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-63. (Pubitemid 30051820)
22. Sugarbaker PH,. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 1994; 37: S115-S122. (Pubitemid 24079569)
23. Shepherd NA, Baxter KJ, Love SB,. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-102. (Pubitemid 27157519)
24. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N,. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 2008; 15: 2388-94.
25. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003; 12: 755-62. (Pubitemid 36993166)
26. van Steenbergen LN, Lemmens VE, Louwman MJ, Straathof JW, Coebergh JW,. Increasing incidence and decreasing mortality of colorectal cancer due to marked cohort effects in southern Netherlands. Eur J Cancer Prev 2009; 18: 145-52.
27. Catalano V, Loupakis F, Graziano F, Torresi U, Bisonni R, Mari D, Fornaro L, Baldelli AM, Giordani P, Rossi D, Alessandroni P, Giustini L, et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer 2009; 100: 881-7.
28. Yan TD, Chu F, Links M, Kam PC, Glenn D, Morris DL,. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival. Eur J Surg Oncol 2006; 32: 1119-24. (Pubitemid 44774401)
29. Nozoe T, Anai H, Nasu S, Sugimachi K,. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000; 75: 103-7.
30. Meulenbeld HJ, van Steenbergen LN, Janssen-Heijnen ML, Lemmens VE, Creemers GJ,. Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004. Ann Oncol 2008; 19: 1600-4.
31. Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goere D, Bonastre J,. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27: 681-5.
32. Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 2007; 14: 128-33. (Pubitemid 44954279)
33. Liberale G, Van Den Eynde M, Hendlisz A, El Nakadi I,. Recommendations for general surgeons facing incidental peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol 2008; 34: 725-6.
34. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D,. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006; 13: 635-44.
35. Piso P, Dahlke MH, Ghali N, Iesalnieks I, Loss M, Popp F, von Breitenbuch P, Agha A, Lang SA, Kullmann F, Schlitt HJ,. Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis 2007; 22: 1295-300. (Pubitemid 47456713)